Drug
Sapropterin Dihydrochloride
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Therapy Non-responder | 364 | 27.3 | 28.9 | signal |
| 2 | Psychomotor Hyperactivity | 134 | 26.8 | 27.4 | signal |
| 3 | Product Prescribing Error | 143 | 20.1 | 20.6 | signal |
| 4 | Gastroenteritis Viral | 75 | 13.8 | 13.9 | signal |
| 5 | Maternal Exposure During Pregnancy | 301 | 11.3 | 11.8 | signal |
| 6 | Pharyngitis Streptococcal | 28 | 8.6 | 8.6 | signal |
| 7 | Seasonal Allergy | 30 | 7.0 | 7.1 | signal |
| 8 | Pregnancy | 42 | 6.9 | 6.9 | signal |
| 9 | Ear Infection | 54 | 6.7 | 6.8 | signal |
| 10 | Abnormal Behaviour | 71 | 5.9 | 6.0 | signal |
| 11 | Abortion Spontaneous | 67 | 5.5 | 5.6 | signal |
| 12 | Aggression | 83 | 5.5 | 5.5 | signal |
| 13 | Exposure During Pregnancy | 93 | 5.0 | 5.0 | signal |
| 14 | Mood Altered | 39 | 4.8 | 4.8 | signal |
| 15 | Rhinorrhoea | 85 | 4.4 | 4.4 | signal |
| 16 | Anger | 44 | 4.3 | 4.3 | signal |
| 17 | Nasal Congestion | 74 | 4.2 | 4.2 | signal |
| 18 | Appendicitis | 11 | 3.9 | 3.9 | signal |
| 19 | Viral Infection | 36 | 3.6 | 3.6 | signal |
| 20 | Abdominal Discomfort | 179 | 3.5 | 3.6 | signal |
| 21 | Increased Appetite | 20 | 3.5 | 3.5 | signal |
| 22 | Gastrooesophageal Reflux Disease | 85 | 3.5 | 3.5 | signal |
| 23 | Abdominal Pain Upper | 217 | 3.5 | 3.6 | signal |
| 24 | Product Taste Abnormal | 14 | 3.4 | 3.5 | signal |
| 25 | Irritability | 61 | 3.4 | 3.4 | signal |
| 26 | Gastritis | 26 | 3.3 | 3.3 | signal |
| 27 | Oropharyngeal Pain | 89 | 3.2 | 3.2 | signal |
| 28 | Gastroenteritis | 14 | 3.2 | 3.2 | signal |
| 29 | Dyspepsia | 94 | 3.2 | 3.2 | signal |
| 30 | Product Dose Omission | 63 | 3.2 | 3.2 | signal |
| 31 | Mood Swings | 30 | 3.1 | 3.1 | signal |
| 32 | Flatulence | 53 | 3.1 | 3.1 | signal |
| 33 | Injection Site Reaction | 62 | 3.0 | 3.0 | signal |
| 34 | Pharyngitis | 11 | 2.9 | 2.9 | signal |
| 35 | Hypophagia | 22 | 2.9 | 2.9 | signal |
| 36 | Nasopharyngitis | 160 | 2.9 | 2.9 | signal |
| 37 | Injection Site Rash | 26 | 2.8 | 2.8 | signal |
| 38 | Hiatus Hernia | 11 | 2.8 | 2.8 | signal |
| 39 | Treatment Noncompliance | 46 | 2.8 | 2.8 | signal |
| 40 | Disturbance In Attention | 44 | 2.7 | 2.7 | signal |
| 41 | Influenza | 86 | 2.5 | 2.6 | signal |
| 42 | Caesarean Section | 9 | 2.5 | 2.5 | signal |
| 43 | Sneezing | 17 | 2.5 | 2.5 | signal |
| 44 | Eating Disorder | 16 | 2.5 | 2.5 | signal |
| 45 | Hunger | 10 | 2.5 | 2.5 | signal |
| 46 | Memory Impairment | 101 | 2.4 | 2.5 | signal |
| 47 | Pharyngeal Swelling | 7 | 2.4 | 2.4 | signal |
| 48 | Affect Lability | 7 | 2.4 | 2.4 | signal |
| 49 | Overdose | 153 | 2.3 | 2.4 | signal |
| 50 | Illness | 69 | 2.3 | 2.3 | signal |
| 51 | Gastric Ulcer | 13 | 2.3 | 2.3 | signal |
| 52 | Sars-cov-2 Test Positive | 9 | 2.2 | 2.2 | signal |
| 53 | Vomiting | 314 | 2.2 | 2.3 | signal |
| 54 | Anxiety | 189 | 2.2 | 2.2 | signal |
| 55 | Migraine | 62 | 2.2 | 2.2 | signal |
| 56 | Nephrolithiasis | 29 | 2.1 | 2.1 | signal |
| 57 | Dental Caries | 7 | 2.1 | 2.1 | no signal |
| 58 | Brain Fog | 9 | 2.0 | 2.0 | no signal |
| 59 | Retching | 13 | 2.0 | 2.0 | signal |
| 60 | Decreased Appetite | 141 | 2.0 | 2.0 | signal |
| 61 | Headache | 378 | 2.0 | 2.1 | no signal |
| 62 | Frequent Bowel Movements | 16 | 2.0 | 2.0 | no signal |
| 63 | Cough | 166 | 2.0 | 2.0 | no signal |
| 64 | Emotional Disorder | 18 | 1.9 | 1.9 | no signal |
| 65 | Weight Fluctuation | 6 | 1.9 | 1.9 | no signal |
| 66 | Crying | 21 | 1.9 | 1.9 | no signal |
| 67 | Secretion Discharge | 7 | 1.9 | 1.9 | no signal |
| 68 | Paraesthesia Oral | 8 | 1.8 | 1.8 | no signal |
| 69 | Drug Exposure During Pregnancy | 19 | 1.8 | 1.8 | no signal |
| 70 | Panic Attack | 20 | 1.8 | 1.8 | no signal |
| 71 | Injection Site Induration | 7 | 1.8 | 1.8 | no signal |
| 72 | Nervousness | 28 | 1.8 | 1.8 | no signal |
| 73 | Premature Baby | 16 | 1.8 | 1.8 | no signal |
| 74 | Anaphylactic Reaction | 29 | 1.7 | 1.8 | no signal |
| 75 | Covid-19 | 92 | 1.7 | 1.7 | no signal |
| 76 | Knee Operation | 5 | 1.7 | 1.7 | no signal |
| 77 | Parkinsonism | 5 | 1.7 | 1.7 | no signal |
| 78 | Faeces Discoloured | 11 | 1.7 | 1.7 | no signal |
| 79 | Salivary Hypersecretion | 5 | 1.7 | 1.7 | no signal |
| 80 | Restlessness | 18 | 1.6 | 1.6 | no signal |
| 81 | Throat Tightness | 13 | 1.6 | 1.6 | no signal |
| 82 | Agitation | 35 | 1.6 | 1.6 | no signal |
| 83 | Feeling Jittery | 9 | 1.6 | 1.6 | no signal |
| 84 | Bipolar Disorder | 5 | 1.5 | 1.5 | no signal |
| 85 | Injection Site Swelling | 34 | 1.5 | 1.5 | no signal |
| 86 | Sinus Congestion | 6 | 1.5 | 1.5 | no signal |
| 87 | Muscle Twitching | 10 | 1.4 | 1.4 | no signal |
| 88 | Gastric Disorder | 15 | 1.4 | 1.4 | no signal |
| 89 | Personality Change | 4 | 1.4 | 1.4 | no signal |
| 90 | Urticaria | 70 | 1.4 | 1.4 | no signal |
| 91 | Injection Site Urticaria | 10 | 1.4 | 1.4 | no signal |
| 92 | Choking | 8 | 1.4 | 1.4 | no signal |
| 93 | Dystonia | 8 | 1.4 | 1.4 | no signal |
| 94 | Paranoia | 7 | 1.3 | 1.3 | no signal |
| 95 | No Therapeutic Response | 5 | 1.3 | 1.3 | no signal |
| 96 | Convulsion | 23 | 1.3 | 1.3 | no signal |
| 97 | Gallbladder Disorder | 7 | 1.3 | 1.3 | no signal |
| 98 | Product Use Complaint | 6 | 1.3 | 1.3 | no signal |
| 99 | Throat Irritation | 17 | 1.3 | 1.3 | no signal |
| 100 | Respiratory Tract Congestion | 6 | 1.2 | 1.2 | no signal |
| 101 | Product Dose Omission Issue | 106 | 1.2 | 1.2 | no signal |
| 102 | Injection Site Erythema | 45 | 1.2 | 1.2 | no signal |
| 103 | Injection Site Pruritus | 23 | 1.1 | 1.1 | no signal |
| 104 | Anosmia | 5 | 1.1 | 1.1 | no signal |
| 105 | Muscle Rigidity | 4 | 1.1 | 1.1 | no signal |
| 106 | Schizophrenia | 4 | 1.1 | 1.1 | no signal |
| 107 | Premature Delivery | 5 | 1.0 | 1.0 | no signal |
| 108 | Injection Site Warmth | 6 | 1.0 | 1.0 | no signal |
| 109 | Serotonin Syndrome | 5 | 0.9 | 0.9 | no signal |
| 110 | Product Physical Issue | 5 | 0.8 | 0.8 | no signal |
| 111 | Extra Dose Administered | 10 | 0.8 | 0.8 | no signal |
| 112 | Dysmenorrhoea | 3 | 0.8 | 0.8 | no signal |
| 113 | Circumstance Or Information Capable Of Leading To Medication Error | 7 | 0.7 | 0.7 | no signal |
| 114 | Product Substitution Issue | 12 | 0.7 | 0.7 | no signal |
| 115 | Injection Site Bruising | 11 | 0.5 | 0.5 | no signal |
| 116 | Menstruation Irregular | 3 | 0.4 | 0.4 | no signal |